Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple MyelomaTimothy Brighton, Hartmut Goldschmidt, Brendan M. Weiss et al.|Clinical Cancer Research|2019Cited by 71
Efficacy and Safety of Single-Agent Ibrutinib in Patients with Mantle Cell Lymphoma Who Progressed after Bortezomib TherapyMichael Wang, Simon Rule, André Goy et al.|Blood|2014Cited by 34